Bone Densitometer Segmentation
Application (Osteoporosis & Osteopenia, Cystic Fibrosis, Chronic Kidney Disease, Body Composition Measurement, Rheumatic Arthritis)
The osteoporosis & osteopenia segment is poised to account for bone densitometer market share of more than 32% by the end of 2037, due to rising cases of osteoporosis & osteopenia owing to the adoption of a sedentary lifestyle. Also, the burgeoning geriatric population who are more prone to osteoporosis & osteopenia is considered to positively contribute towards segment growth. As per the data provided by the World Health Organization (WHO), the share of the population of age 60 or above in the world increased from 1 billion to 1.4 billion in 2022 and is projected to double by 2050 reaching around 2.1 billion.
End-User (Hospitals, Clinics)
Hospital segment is expected to hold bone densitometer market share of over 46% by the end of 2037, attributed to the burgeoning of the geriatric population with a disability who requires full-time assistance and generally admits into hospitals. Moreover, the increasing investment in hospitals by governments of different nations, along with the rising healthcare expenditure, and the availability of the dedicated orthopedic section in the hospital. It was noted that spending on health care in the United States increased 2.7 percent in 2021 to USD 4.3 trillion, or USD 12,914 per person. Total expenditure on healthcare accounted for more than 18 percent of the region’s GDP.
Our in-depth analysis of the global market includes the following segments:
|
Type |
|
|
Technology |
|
|
Scan |
|
|
Application |
|
|
End User |
|
